US Bancorp
AMAG

US Bancorp’s AMAG Pharmaceuticals AMAG Stock Holding History

US Bancorp’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-145
Closed -$2K – 3883
2019
Q4 		$2K Hold
145
– – ﹤0.01% 3528
2019
Q3 		$2K Sell
145
-111
-43% -$1.17K ﹤0.01% 3460
2019
Q2 		$3K Buy
256
+160
+167% +$1.73K ﹤0.01% 3418
2019
Q1 		$1K Hold
96
– – ﹤0.01% 3552
2018
Q4 		$1K Sell
96
-60
-38% -$1.14K ﹤0.01% 3554
2018
Q3 		$3K Hold
156
– – ﹤0.01% 3460
2018
Q2 		$3K Sell
156
-573
-79% -$12.7K ﹤0.01% 3460
2018
Q1 		$15K Sell
729
-1,299
-64% -$22K ﹤0.01% 3044
2017
Q4 		$27K Sell
2,028
-185
-8% -$2.79K ﹤0.01% 2835
2017
Q3 		$41K Sell
2,213
-275
-11% -$5.13K ﹤0.01% 2654
2017
Q2 		$46K Sell
2,488
-657
-21% -$13K ﹤0.01% 2582
2017
Q1 		$71K Sell
3,145
-21,349
-87% -$511K ﹤0.01% 2309
2016
Q4 		$853K Sell
24,494
-3,312
-12% -$98.9K ﹤0.01% 1139
2016
Q3 		$682K Sell
27,806
-893
-3% -$22.3K ﹤0.01% 1217
2016
Q2 		$686K Buy
28,699
+9,677
+51% +$222K ﹤0.01% 1184
2016
Q1 		$445K Sell
19,022
-1,162
-6% -$27.6K ﹤0.01% 1338
2015
Q4 		$609K Buy
20,184
+2,542
+14% +$82.1K ﹤0.01% 1218
2015
Q3 		$700K Buy
17,642
+2,001
+13% +$124K ﹤0.01% 1140
2015
Q2 		$1.08M Sell
15,641
-5,160
-25% -$325K ﹤0.01% 981
2015
Q1 		$1.14M Buy
20,801
+10,609
+104% +$506K ﹤0.01% 964
2014
Q4 		$434K Buy
10,192
+6,592
+183% +$238K ﹤0.01% 1404
2014
Q3 		$114K Sell
3,600
-233
-6% -$4.97K ﹤0.01% 2042
2014
Q2 		$80K Sell
3,833
-38
-1% -$702 ﹤0.01% 2254
2014
Q1 		$74K Buy
3,871
+6
+0.2% +$127 ﹤0.01% 2287
2013
Q4 		$94K Hold
3,865
– – ﹤0.01% 2138
2013
Q3 		$83K Sell
3,865
-6
-0.2% -$142 ﹤0.01% 2115
2013
Q2 		$86K Buy
+3,871
New +$85.3K ﹤0.01% 2063

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

US Bancorp's AMAG Position: Q1 2020 in Review

US Bancorp sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 145 shares — an estimated $2K sold.

US Bancorp first reported a position in AMAG in Q2 2013 and held it in 27 quarters. The position peaked at $1.14M in Q1 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • US Bancorp reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • US Bancorp sold 145 AMAG Pharmaceuticals shares in Q1 2020, an estimated $2K.
  • US Bancorp first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • US Bancorp's AMAG Pharmaceuticals position peaked at $1.14M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on US Bancorp's 13F filing for Q1 2020, filed 13 May 2020.